Renowned oncologist Dr. Steven Grossman steps into prestigious endowed chair role at Hoag, ushering in a new era of innovation, immunotherapy breakthroughs, and personalized cancer care fueled by philanthropy.
Steven Grossman, MD, PhD, executive medical director of the Hoag Family Cancer Institute, has been appointed as the holder of the Grace E. Hoag Executive Medical Director Endowed Chair, Hoag Family Cancer Institute. Filling this philanthropically endowed position marks an exciting new chapter in the progress of the Hoag Family Cancer Institute.
Dr. Grossman, a renowned expert in cancer research and treatment, brings a wealth of experience and leadership to this prestigious role. With a career marked by groundbreaking contributions toward understanding the molecular basis of cancer and development of new cancer therapies, Dr. Grossman is poised to shape the future of cancer care at Hoag. His vision for the cancer institute includes expanding access to advanced treatments, fostering world-class research initiatives, and providing patients with innovative, personalized care.
Steven Grossman, MD, PhD
Grace E. Hoag Executive Medical Director Endowed Chair, Hoag Family Cancer Institute
“I am honored to be named the Grace E. Hoag Executive Medical Director Endowed Chair,” said Dr. Grossman. “This endowed chair not only supports my work but, more importantly, enables our cancer team to focus on translational research, bridging the gap between laboratory discoveries and clinical trials and, ultimately, the most advanced treatments for our patients. This is an incredible opportunity for which I’m truly grateful.”
Dr. Grossman’s appointment also highlights the pivotal role of philanthropy in Hoag’s continued success. “The level of philanthropic support that Hoag receives from the Orange County community is nothing short of remarkable,” he said. “It’s something that’s rare, even among major cancer centers. The community’s involvement helps bring vital resources into cancer care, supporting new technologies, clinical trials, and translational research efforts.”
His role will be instrumental in advancing the institute’s goals, particularly in the areas of immunotherapy and personalized cancer care. His plans include expanding research and clinical trials, developing novel treatments, and implementing innovative education programs to train the next generation of oncology specialists.
“I’m excited about the unique model at Hoag,” Dr. Grossman shared. “The combination of clinical research and discovery is uncommon in community health systems, and it’s what makes Hoag stand out. We are not just treating patients; we are actively shaping the future of cancer care through groundbreaking research.”
Hoag’s endowed chair program, established to recognize and support our most distinguished physicians, includes 22 chairs spanning diverse specialties, including cancer, cardiovascular care, and neuroscience. These chairs are critical in supporting Hoag’s mission to deliver transformative care through research and clinical advancements, with philanthropic support from our dedicated community.
“Hoag’s endowed chair program is a powerful example of the profound impact that philanthropy has on advancing health care,” said Caroline A. Pereira, MBA, president of the Hoag Hospital Foundation. “With the support of generous donors, we are able to attract top talent like Dr. Grossman, whose expertise and leadership will have a lasting impact on cancer care, research, and patient outcomes. We are thrilled to welcome Dr. Grossman to this important role and look forward to the progress he will lead in the fight against cancer.”
Sign up for our Newsletter
